Search research articles
Contact Us
Filters
Showing results (31-40 of 67) with videos related to
Page
of 7
Sort By:
Science Translational Medicine
|
January 4, 2013
A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication
Felipe García, Nuria Climent, Alberto C Guardo, et al.
Journal of the International AIDS Society
|
November 14, 2014
Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients
Josep M Gatell, Javier O Morales-Ramirez, Debbie P Hagins, et al.
Immunology
|
April 20, 2011
The reconstitution of the thymus in immunosuppressed individuals restores CD4-specific cellular and humoral immune responses
Montserrat Plana, Felipe Garcia, Laila Darwich, et al.
Plos One
|
December 31, 2015
Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort
César Garriga, Patricia García de Olalla, Josep M Miró, et al.
Antiviral Therapy
|
January 18, 2005
Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C
Montserrat Laguno, Jordi Blanch, Javier Murillas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 27, 2005
Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study)
Esteban Ribera, Carlos Azuaje, Rosa M Lopez, et al.
Journal of the International AIDS Society
|
October 5, 2014
Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation
Berta Torres, Alberto C Guardo, Lorna Leal, et al.
The Journal of Antimicrobial Chemotherapy
|
June 25, 2025
48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial
Elisa de Lazzari, Silvana Di Gregorio, Jhon Rojas, et al.
Journal of Virology
|
January 20, 2012
Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1
Edurne Gallastegui, Brett Marshall, David Vidal, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
October 5, 2010
[Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy]
Josep M Llibre, Antonio Antela, José Ramón Arribas, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 67) with videos related to
Sort By:
Page
of 7
Science Translational Medicine
|
January 4, 2013
A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication
Felipe García, Nuria Climent, Alberto C Guardo, et al.
Journal of the International AIDS Society
|
November 14, 2014
Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients
Josep M Gatell, Javier O Morales-Ramirez, Debbie P Hagins, et al.
Immunology
|
April 20, 2011
The reconstitution of the thymus in immunosuppressed individuals restores CD4-specific cellular and humoral immune responses
Montserrat Plana, Felipe Garcia, Laila Darwich, et al.
Plos One
|
December 31, 2015
Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort
César Garriga, Patricia García de Olalla, Josep M Miró, et al.
Antiviral Therapy
|
January 18, 2005
Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C
Montserrat Laguno, Jordi Blanch, Javier Murillas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 27, 2005
Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study)
Esteban Ribera, Carlos Azuaje, Rosa M Lopez, et al.
Journal of the International AIDS Society
|
October 5, 2014
Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation
Berta Torres, Alberto C Guardo, Lorna Leal, et al.
The Journal of Antimicrobial Chemotherapy
|
June 25, 2025
48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trial
Elisa de Lazzari, Silvana Di Gregorio, Jhon Rojas, et al.
Journal of Virology
|
January 20, 2012
Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1
Edurne Gallastegui, Brett Marshall, David Vidal, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
October 5, 2010
[Role of fixed-dose combinations of antiretrovirals in HIV-1 therapy]
Josep M Llibre, Antonio Antela, José Ramón Arribas, et al.
Page
of 7